General Information of This Drug (ID: DMWVIGP)

Drug Name
Digitoxin   DMWVIGP
Synonyms
Acedoxin; Asthenthilo; Cardidigin; Cardigin; Cardiolanata; Carditalin; Carditoxin; Coramedan; Cristapurat; Crystodigin; Digicor; Digilanid; Digilong; Digimed; Digimerck; Digipural; Digisidin; Digitoksim; Digitoksin; Digitophyllin; Digitossina; Digitoxina; Digitoxine; Digitoxinum; Digitoxoside; Digitoxosidum; Digitrin; Ditaven; Glucodigin; Lanatoxin; Lanostabil; Monodigitoxoside; Myodigin; Natigal; Pandigal; Panlanat; Purodigin; Purpurid; Tardigal; Unidigin; Crystalline digitalin; Digitaline cristallisee; Digitaline nativelle; Digitalinum verum; Digitossina [DCIT]; Digitoxigenin tridigitoxoside; LT00244784; Crystodigin (TN); De-Tone; Digitalin, crystalline; Digitaline (TN); Digitoxigenin-tridigitoxosid; Digitoxigenin-tridigitoxosid [German]; Digitoxina [INN-Spanish]; Digitoxine [INN-French]; Digitoxinum [INN-Latin]; Mono-digitoxid; Mono-digitoxid [German]; Mono-glycocard; Purodigin, crystalline; Tri-digitoxoside; Tri-digitoxoside [German]; Digitoxin [INN:BAN:JAN]; Digitoxin (JP15/USP/INN); Inhibits Na+/K+ ATPase; 5.beta.-Card-20(22)-enolide, 3.beta.,14-dihydroxy-, 3-[tris-(digitoxoside)]
Indication
Disease Entry ICD 11 Status REF
Arrhythmia BC9Z Approved [1]
Congestive cardiac insufficiency BD1Z Approved [1]
Heart failure BD10-BD13 Approved [1]
Therapeutic Class
Antiarrhythmic Agents
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

267 Investigative Drug Combination(s) Consisting of This drug
Normalized Drug Combination Synergy Score
Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.
DrugCom Name DrugCom ID Component Drug Indication REF
ABIRATERONE + Digitoxin DCFRJ3A ABIRATERONE Anaplastic large cell lymphoma (Cell Line: SR) [2]
ABIRATERONE + Digitoxin DCP1WD6 ABIRATERONE Glioma (Cell Line: SF-268) [2]
ABIRATERONE + Digitoxin DCRG75V ABIRATERONE Renal cell carcinoma (Cell Line: UO-31) [2]
ABIRATERONE + Digitoxin DC9Z7UN ABIRATERONE Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
ABIRATERONE + Digitoxin DCQBY84 ABIRATERONE Invasive ductal carcinoma (Cell Line: HS 578T) [3]
ABIRATERONE + Digitoxin DC135N2 ABIRATERONE Amelanotic melanoma (Cell Line: MDA-MB-435) [4]
ABIRATERONE + Digitoxin DCWWV3F ABIRATERONE Malignant melanoma (Cell Line: LOX IMVI) [4]
ABIRATERONE + Digitoxin DC5OZXB ABIRATERONE Melanoma (Cell Line: UACC-257) [4]
ABIRATERONE + Digitoxin DC4C1TV ABIRATERONE Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [4]
Amonafide + Digitoxin DCZC6HY Amonafide Adenocarcinoma (Cell Line: DU-145) [2]
Amonafide + Digitoxin DC84S2B Amonafide Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
Amonafide + Digitoxin DC4QVPI Amonafide Anaplastic large cell lymphoma (Cell Line: SR) [2]
Amonafide + Digitoxin DCKB09K Amonafide Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [2]
Amonafide + Digitoxin DC2BSCR Amonafide Chronic myelogenous leukemia (Cell Line: K-562) [2]
Amonafide + Digitoxin DCBCDZZ Amonafide Clear cell renal cell carcinoma (Cell Line: A498) [2]
Amonafide + Digitoxin DCZJNIA Amonafide Glioma (Cell Line: SF-539) [2]
Amonafide + Digitoxin DCTD209 Amonafide Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [2]
Anastrozole + Digitoxin DCYH82Y Anastrozole Adenocarcinoma (Cell Line: DU-145) [2]
Anastrozole + Digitoxin DCZ76CW Anastrozole Amelanotic melanoma (Cell Line: MDA-MB-435) [2]
Anastrozole + Digitoxin DC1OGW8 Anastrozole Chronic myelogenous leukemia (Cell Line: K-562) [2]
Anastrozole + Digitoxin DCZ2SH5 Anastrozole Cutaneous melanoma (Cell Line: SK-MEL-5) [2]
Anastrozole + Digitoxin DCBLDDE Anastrozole Glioma (Cell Line: SF-268) [2]
Anastrozole + Digitoxin DC2WRDX Anastrozole Large cell lung carcinoma (Cell Line: NCI-H460) [2]
Anastrozole + Digitoxin DC3K4Y3 Anastrozole Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [2]
Anastrozole + Digitoxin DCHK22O Anastrozole Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [2]
Anastrozole + Digitoxin DCNMBQF Anastrozole Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [2]
Anastrozole + Digitoxin DCEOTIC Anastrozole Carcinoma (Cell Line: MCF7) [3]
Arfolitixorin + Digitoxin DC9JCO0 Arfolitixorin Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [4]
BIO-300 + Digitoxin DCQ6HWG BIO-300 Clear cell renal cell carcinoma (Cell Line: A498) [2]
BIO-300 + Digitoxin DCH70R2 BIO-300 Glioma (Cell Line: SF-539) [2]
BIO-300 + Digitoxin DCN15US BIO-300 Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [4]
Bleomycin + Digitoxin DCDTT5R Bleomycin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
Bleomycin + Digitoxin DCENO7E Bleomycin Anaplastic large cell lymphoma (Cell Line: SR) [2]
Bleomycin + Digitoxin DC6805C Bleomycin Astrocytoma (Cell Line: SNB-19) [2]
Bleomycin + Digitoxin DC43BFF Bleomycin Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [2]
Bleomycin + Digitoxin DCCPUPT Bleomycin Clear cell renal cell carcinoma (Cell Line: A498) [2]
Bleomycin + Digitoxin DC2ESS0 Bleomycin Glioma (Cell Line: SF-539) [2]
Bleomycin + Digitoxin DCON03K Bleomycin Amelanotic melanoma (Cell Line: MDA-MB-435) [4]
Bleomycin + Digitoxin DCP30WW Bleomycin Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [4]
Cabazitaxel + Digitoxin DC72SEL Cabazitaxel Adenocarcinoma (Cell Line: HT29) [2]
Cabazitaxel + Digitoxin DCAZH9E Cabazitaxel Adenocarcinoma (Cell Line: HCT116) [2]
Cabazitaxel + Digitoxin DCE1VZ5 Cabazitaxel Adenocarcinoma (Cell Line: HCC-2998) [2]
Cabazitaxel + Digitoxin DCOZX4K Cabazitaxel Adenocarcinoma (Cell Line: HCT-15) [2]
Cabazitaxel + Digitoxin DCTQ49D Cabazitaxel Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
Cabazitaxel + Digitoxin DCXBWY7 Cabazitaxel Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Cabazitaxel + Digitoxin DCG3EXU Cabazitaxel Anaplastic large cell lymphoma (Cell Line: SR) [2]
Cabazitaxel + Digitoxin DC22EZS Cabazitaxel Clear cell renal cell carcinoma (Cell Line: 786-0) [2]
Cabazitaxel + Digitoxin DCFLU7A Cabazitaxel Clear cell renal cell carcinoma (Cell Line: A498) [2]
Cabazitaxel + Digitoxin DCB425F Cabazitaxel Lung adenocarcinoma (Cell Line: NCI-H522) [2]
Cabazitaxel + Digitoxin DCHKX4W Cabazitaxel Malignant melanoma (Cell Line: UACC62) [2]
Cabazitaxel + Digitoxin DC2R6KA Cabazitaxel Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [2]
Cabazitaxel + Digitoxin DC4NQ9R Cabazitaxel Prostate carcinoma (Cell Line: PC-3) [2]
Cabazitaxel + Digitoxin DCCI6IA Cabazitaxel Renal cell carcinoma (Cell Line: SN12C) [2]
Cabazitaxel + Digitoxin DC7SOWI Cabazitaxel Carcinoma (Cell Line: RXF 393) [3]
Cabazitaxel + Digitoxin DCY7PWB Cabazitaxel Invasive ductal carcinoma (Cell Line: BT-549) [3]
Crizotinib + Digitoxin DC2B108 Crizotinib Anaplastic large cell lymphoma (Cell Line: SR) [2]
Crizotinib + Digitoxin DCBLO11 Crizotinib Clear cell renal cell carcinoma (Cell Line: TK-10) [2]
Crizotinib + Digitoxin DC654JN Crizotinib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [2]
Crizotinib + Digitoxin DC1V09B Crizotinib Large cell lung carcinoma (Cell Line: NCI-H460) [2]
Crizotinib + Digitoxin DCYAASH Crizotinib Plasma cell myeloma (Cell Line: RPMI-8226) [2]
Dacarbazine + Digitoxin DCUJADG Dacarbazine Glioma (Cell Line: SF-539) [2]
Dacarbazine + Digitoxin DCWGACP Dacarbazine Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [2]
Dactinomycin + Digitoxin DCCEGMP Dactinomycin Adenocarcinoma (Cell Line: OVCAR3) [4]
Dactinomycin + Digitoxin DCVWY0O Dactinomycin Adenocarcinoma (Cell Line: A549) [4]
Dactinomycin + Digitoxin DCZ9G6M Dactinomycin Adenocarcinoma (Cell Line: HT29) [4]
Dactinomycin + Digitoxin DCDM34J Dactinomycin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [4]
Dactinomycin + Digitoxin DCKUHMN Dactinomycin Anaplastic large cell lymphoma (Cell Line: SR) [4]
Dactinomycin + Digitoxin DCP3EK2 Dactinomycin Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [4]
Dactinomycin + Digitoxin DCJPXFQ Dactinomycin Cutaneous melanoma (Cell Line: SK-MEL-5) [4]
Dactinomycin + Digitoxin DC0TVVX Dactinomycin Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [4]
Dexrazoxane + Digitoxin DCORI0M Dexrazoxane Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
Dexrazoxane + Digitoxin DCTCA5J Dexrazoxane Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Dexrazoxane + Digitoxin DCV95FC Dexrazoxane Glioma (Cell Line: SF-268) [2]
Dexrazoxane + Digitoxin DCGQWGD Dexrazoxane High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [4]
Dexrazoxane + Digitoxin DCAHLF0 Dexrazoxane Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [4]
DFN-15 + Digitoxin DCRH3X1 DFN-15 Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [4]
Digitoxin + Pentostatin DCAXJJR Pentostatin Adenocarcinoma (Cell Line: OVCAR3) [2]
Digitoxin + Hepzato DCGC62M Hepzato Adenocarcinoma (Cell Line: HT29) [2]
Digitoxin + Ixabepilone DCO5B2W Ixabepilone Adenocarcinoma (Cell Line: HCT-15) [2]
Digitoxin + Ixabepilone DCFE3OX Ixabepilone Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
Digitoxin + Dactinomycin DCI9ZII Dactinomycin Adenocarcinoma (Cell Line: HCT116) [2]
Digitoxin + Lapatinib DCFXT0Q Lapatinib Clear cell renal cell carcinoma (Cell Line: A498) [2]
Digitoxin + Lapatinib DCWPU0E Lapatinib Glioma (Cell Line: SF-295) [2]
Digitoxin + PMID28460551-Compound-2 DCUJMDV PMID28460551-Compound-2 Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Digitoxin + PMID28460551-Compound-2 DCV4HGW PMID28460551-Compound-2 Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [2]
Digitoxin + PMID28460551-Compound-2 DCIY727 PMID28460551-Compound-2 Renal cell carcinoma (Cell Line: UO-31) [2]
Digitoxin + Cyclophosphamide DCZAXNO Cyclophosphamide Glioma (Cell Line: SF-539) [2]
Digitoxin + Arsenic trioxide DC9OU63 Arsenic trioxide Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
Digitoxin + Arsenic trioxide DC039Q7 Arsenic trioxide Chronic myelogenous leukemia (Cell Line: K-562) [2]
Digitoxin + Arsenic trioxide DCUKX5B Arsenic trioxide Cutaneous melanoma (Cell Line: SK-MEL-5) [2]
Digitoxin + Arsenic trioxide DCEN60M Arsenic trioxide Melanoma (Cell Line: UACC-257) [2]
Digitoxin + Plicamycin DCU4HRG Plicamycin Adenocarcinoma (Cell Line: HCC-2998) [2]
Digitoxin + Nilotinib DC0IAFY Nilotinib Adenocarcinoma (Cell Line: OVCAR3) [2]
Digitoxin + Nilotinib DCGK14D Nilotinib Adenocarcinoma (Cell Line: HT29) [2]
Digitoxin + Nilotinib DCXZBKJ Nilotinib Amelanotic melanoma (Cell Line: M14) [2]
Digitoxin + Nilotinib DCH1MIJ Nilotinib Amelanotic melanoma (Cell Line: MDA-MB-435) [2]
Digitoxin + Nilotinib DCG3UCK Nilotinib Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [2]
Digitoxin + Nilotinib DC0ZW8S Nilotinib Cutaneous melanoma (Cell Line: SK-MEL-5) [2]
Digitoxin + Nilotinib DCOW5N4 Nilotinib Lung adenocarcinoma (Cell Line: HOP-62) [2]
Digitoxin + Triapine DCYRXOV Triapine Anaplastic large cell lymphoma (Cell Line: SR) [2]
Digitoxin + 10-hydroxycamptothecin DCOR1GR 10-hydroxycamptothecin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
Digitoxin + SCH 727965 DC4QCRS SCH 727965 Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [2]
Digitoxin + SCH 727965 DCQP3OV SCH 727965 Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [2]
Digitoxin + Ifosfamide DCLF1JC Ifosfamide Large cell lung carcinoma (Cell Line: NCI-H460) [2]
Digitoxin + Ifosfamide DCUD92W Ifosfamide Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [2]
Digitoxin + Docetaxel DCV6E2K Docetaxel Clear cell renal cell carcinoma (Cell Line: CAKI-1) [2]
Digitoxin + Raloxifene DCKEYE4 Raloxifene Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Digitoxin + Raloxifene DCTE9U0 Raloxifene Amelanotic melanoma (Cell Line: M14) [2]
Digitoxin + Raloxifene DCHSNID Raloxifene Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [2]
Digitoxin + Raloxifene DC7EFJD Raloxifene High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [2]
Digitoxin + Raloxifene DCE44UW Raloxifene Large cell lung carcinoma (Cell Line: NCI-H460) [2]
Digitoxin + Raloxifene DC5NQ7L Raloxifene Malignant melanoma (Cell Line: UACC62) [2]
Digitoxin + Raloxifene DCLFBX1 Raloxifene Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [2]
Digitoxin + Sirolimus DC7SLLH Sirolimus Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Digitoxin + Mitomycin DCNURVI Mitomycin Adenocarcinoma (Cell Line: A549) [2]
Digitoxin + Mitomycin DC36ZPL Mitomycin Adenocarcinoma (Cell Line: HCT116) [2]
Digitoxin + Mitomycin DCLKPHW Mitomycin Adenocarcinoma (Cell Line: HCT-15) [2]
Digitoxin + Mitomycin DCDXBBU Mitomycin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
Digitoxin + Mitomycin DC5OIND Mitomycin Anaplastic large cell lymphoma (Cell Line: SR) [2]
Digitoxin + Mitomycin DCS4N8D Mitomycin Astrocytoma (Cell Line: SNB-19) [2]
Digitoxin + Mitomycin DCQEHHH Mitomycin Cutaneous melanoma (Cell Line: SK-MEL-5) [2]
Digitoxin + Mitomycin DCVVOYG Mitomycin Glioma (Cell Line: SF-539) [2]
Digitoxin + Mitomycin DCM3OWN Mitomycin Large cell lung carcinoma (Cell Line: NCI-H460) [2]
Digitoxin + Mitomycin DCNWFNJ Mitomycin Malignant melanoma (Cell Line: UACC62) [2]
Digitoxin + SY-1425 DCLQ4Z1 SY-1425 Malignant melanoma (Cell Line: UACC62) [2]
Digitoxin + Idarubicin DCZXXQ2 Idarubicin Adenocarcinoma (Cell Line: OVCAR3) [2]
Digitoxin + Imatinib DCLZ4B7 Imatinib Large cell lung carcinoma (Cell Line: NCI-H460) [2]
Digitoxin + Bleomycin DCY0XD6 Bleomycin Anaplastic large cell lymphoma (Cell Line: SR) [2]
Digitoxin + Bleomycin DCD2RNH Bleomycin Chronic myelogenous leukemia (Cell Line: K-562) [2]
Digitoxin + Bleomycin DCBOT5L Bleomycin Cutaneous melanoma (Cell Line: SK-MEL-5) [2]
Digitoxin + Bleomycin DC0EN6J Bleomycin High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [2]
Digitoxin + Bortezomib DC17VAK Bortezomib Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
Digitoxin + Bortezomib DCZGZTM Bortezomib Anaplastic large cell lymphoma (Cell Line: SR) [2]
Digitoxin + Bortezomib DC0LKUV Bortezomib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [2]
Digitoxin + Valrubicin DCRBCI4 Valrubicin Amelanotic melanoma (Cell Line: M14) [2]
Digitoxin + Valrubicin DCP8YL9 Valrubicin Glioma (Cell Line: SF-295) [2]
Digitoxin + Valrubicin DC9HF1Z Valrubicin Glioma (Cell Line: SF-268) [2]
Digitoxin + Valrubicin DCT3VKB Valrubicin Lung adenocarcinoma (Cell Line: MDA-MB-231) [2]
Digitoxin + Cisplatin DCRA1IM Cisplatin Adenocarcinoma (Cell Line: A549) [2]
Digitoxin + Cisplatin DCY0CSD Cisplatin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Digitoxin + Cisplatin DC8CTGO Cisplatin Anaplastic large cell lymphoma (Cell Line: SR) [2]
Digitoxin + Cisplatin DCQM69E Cisplatin Astrocytoma (Cell Line: U251) [2]
Digitoxin + Cisplatin DCPRJIV Cisplatin Cutaneous melanoma (Cell Line: SK-MEL-5) [2]
Digitoxin + Cisplatin DCDVGRF Cisplatin Lung adenocarcinoma (Cell Line: HOP-62) [2]
Digitoxin + Cisplatin DC3YJT5 Cisplatin Lung adenocarcinoma (Cell Line: EKVX) [2]
Digitoxin + Cisplatin DCHJ5RQ Cisplatin Malignant melanoma (Cell Line: LOX IMVI) [2]
Digitoxin + Cisplatin DC2Y0J3 Cisplatin Melanoma (Cell Line: MALME-3M) [2]
Digitoxin + Cisplatin DCSVKDC Cisplatin Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [2]
Digitoxin + Cisplatin DCXB7SO Cisplatin Papillary renal cell carcinoma (Cell Line: ACHN) [2]
Digitoxin + Cisplatin DCX7KLZ Cisplatin Plasma cell myeloma (Cell Line: RPMI-8226) [2]
Digitoxin + Sorafenib DCGKJ93 Sorafenib Lung adenocarcinoma (Cell Line: EKVX) [2]
Digitoxin + ER819762 DC0F9LB ER819762 Adenocarcinoma (Cell Line: A549) [2]
Digitoxin + ER819762 DC9FBZ8 ER819762 Prostate carcinoma (Cell Line: PC-3) [2]
Digitoxin + ER819762 DCLRNYN ER819762 Renal cell carcinoma (Cell Line: SN12C) [2]
Digitoxin + Romidepsin DCI9LTA Romidepsin Adenocarcinoma (Cell Line: NCIH23) [2]
Digitoxin + Romidepsin DCHMJNT Romidepsin Lung adenocarcinoma (Cell Line: MDA-MB-231) [2]
Digitoxin + Azacitidine DC225IB Azacitidine Adenocarcinoma (Cell Line: HT29) [2]
Digitoxin + Azacitidine DCSK9VL Azacitidine Malignant melanoma (Cell Line: UACC62) [2]
Digitoxin + Pomalidomide DCUVUZD Pomalidomide Glioblastoma (Cell Line: SNB-75) [2]
Digitoxin + Vinflunine DCF8C2P Vinflunine Anaplastic large cell lymphoma (Cell Line: SR) [2]
Digitoxin + Vinflunine DCEOJTX Vinflunine Astrocytoma (Cell Line: SNB-19) [2]
Digitoxin + Vinflunine DCMYCWC Vinflunine High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [2]
Digitoxin + Vinflunine DCZQV2C Vinflunine Malignant melanoma (Cell Line: UACC62) [2]
Digitoxin + Vinflunine DCZDYKM Vinflunine Non-small cell lung carcinoma (Cell Line: HOP-92) [2]
Digitoxin + Vinflunine DCYAJUQ Vinflunine Plasma cell myeloma (Cell Line: RPMI-8226) [2]
Digitoxin + Mercaptopurine DCFC1UL Mercaptopurine High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [2]
Digitoxin + Taxol DC67E0P Taxol Chronic myelogenous leukemia (Cell Line: K-562) [2]
Digitoxin + Taxol DCC486V Taxol Glioma (Cell Line: SF-295) [2]
Digitoxin + Taxol DC9R1VC Taxol Plasma cell myeloma (Cell Line: RPMI-8226) [2]
Digitoxin + PMID28870136-Compound-43 DCZS8UG PMID28870136-Compound-43 Glioma (Cell Line: SF-295) [2]
Digitoxin + FORMESTANE DC1LW86 FORMESTANE Anaplastic large cell lymphoma (Cell Line: SR) [2]
Digitoxin + Aminolevulinic Acid Hydrochloride DC6TW8M Aminolevulinic Acid Hydrochloride Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
Digitoxin + Aminolevulinic Acid Hydrochloride DCT500K Aminolevulinic Acid Hydrochloride Anaplastic large cell lymphoma (Cell Line: SR) [2]
Digitoxin + Aminolevulinic Acid Hydrochloride DC2VQ89 Aminolevulinic Acid Hydrochloride Large cell lung carcinoma (Cell Line: NCI-H460) [2]
Digitoxin + Aminolevulinic Acid Hydrochloride DC8363F Aminolevulinic Acid Hydrochloride Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [2]
Digitoxin + Estramustine DCGFAYN Estramustine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
Digitoxin + Estramustine DCPHULZ Estramustine Large cell lung carcinoma (Cell Line: NCI-H460) [2]
Digitoxin + Estramustine DC1ESK3 Estramustine Malignant melanoma (Cell Line: UACC62) [2]
Digitoxin + Estramustine DCCHLJZ Estramustine Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [2]
Digitoxin + Busulfan DCBF0YK Busulfan Glioblastoma (Cell Line: SNB-75) [2]
Digitoxin + Dasatinib DC34BJ9 Dasatinib Adenocarcinoma (Cell Line: HCC-2998) [2]
Digitoxin + Dasatinib DCF1HQ7 Dasatinib Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [2]
Digitoxin + Cyclophosphamide DCRIRDJ Cyclophosphamide Carcinoma (Cell Line: MCF7) [3]
Digitoxin + Plicamycin DCPNQ3X Plicamycin Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
Digitoxin + Nilotinib DCWOHN2 Nilotinib Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
Digitoxin + Mitomycin DCKA68P Mitomycin Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
Digitoxin + Mitomycin DCZTPVR Mitomycin Invasive ductal carcinoma (Cell Line: T-47D) [3]
Digitoxin + Imatinib DC9FNOX Imatinib Invasive ductal carcinoma (Cell Line: T-47D) [3]
Digitoxin + Sorafenib DCZ9HN6 Sorafenib Invasive ductal carcinoma (Cell Line: T-47D) [3]
Digitoxin + Vinflunine DCNC5Z0 Vinflunine Carcinoma (Cell Line: MCF7) [3]
Digitoxin + Vinflunine DCDW38J Vinflunine Invasive ductal carcinoma (Cell Line: HS 578T) [3]
Digitoxin + Taxol DC3OA1H Taxol Invasive ductal carcinoma (Cell Line: HS 578T) [3]
Digitoxin + FORMESTANE DCK2JKL FORMESTANE Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
Digitoxin + FORMESTANE DCFFF9X FORMESTANE Invasive ductal carcinoma (Cell Line: T-47D) [3]
Digitoxin + Aminolevulinic Acid Hydrochloride DCW291W Aminolevulinic Acid Hydrochloride Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
Digitoxin + Estramustine DCVSXTY Estramustine Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
Epirubicin + Digitoxin DCHBOX4 Epirubicin Renal cell carcinoma (Cell Line: UO-31) [2]
Epirubicin + Digitoxin DCXVUKE Epirubicin Carcinoma (Cell Line: MCF7) [3]
Epirubicin + Digitoxin DCSZ9UG Epirubicin Invasive ductal carcinoma (Cell Line: HS 578T) [3]
Epirubicin + Digitoxin DCOLIIW Epirubicin Malignant melanoma (Cell Line: LOX IMVI) [4]
Epirubicin + Digitoxin DCGHYLG Epirubicin Melanoma (Cell Line: UACC-257) [4]
Epirubicin + Digitoxin DCFZDTX Epirubicin Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [4]
Fludarabine + Digitoxin DCR46XO Fludarabine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Fludarabine + Digitoxin DCK2NC0 Fludarabine Anaplastic large cell lymphoma (Cell Line: SR) [2]
Fludarabine + Digitoxin DC7OGH1 Fludarabine Large cell lung carcinoma (Cell Line: NCI-H460) [4]
Fludarabine + Digitoxin DCW6HZB Fludarabine Malignant melanoma (Cell Line: UACC62) [4]
Gefitinib + Digitoxin DCQ4BWQ Gefitinib Adenocarcinoma (Cell Line: A549) [2]
Gefitinib + Digitoxin DCNN93R Gefitinib Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [2]
Gefitinib + Digitoxin DCIGSTW Gefitinib Amelanotic melanoma (Cell Line: MDA-MB-435) [2]
Gefitinib + Digitoxin DC9AVZT Gefitinib Clear cell renal cell carcinoma (Cell Line: A498) [2]
Gefitinib + Digitoxin DCUV21H Gefitinib Cutaneous melanoma (Cell Line: SK-MEL-5) [2]
Gefitinib + Digitoxin DCI0YJ1 Gefitinib Glioblastoma (Cell Line: SNB-75) [2]
Gefitinib + Digitoxin DCB1JS7 Gefitinib Glioma (Cell Line: SF-268) [2]
Gefitinib + Digitoxin DC53Y8T Gefitinib High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [2]
Gefitinib + Digitoxin DCHXZL7 Gefitinib Large cell lung carcinoma (Cell Line: NCI-H460) [2]
Gefitinib + Digitoxin DCX38RK Gefitinib Melanoma (Cell Line: MALME-3M) [2]
Gefitinib + Digitoxin DCZB1DC Gefitinib Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [2]
Gefitinib + Digitoxin DCHNTDG Gefitinib Non-small cell lung carcinoma (Cell Line: HOP-92) [2]
Gefitinib + Digitoxin DC642D1 Gefitinib Plasma cell myeloma (Cell Line: RPMI-8226) [2]
Gefitinib + Digitoxin DCK35F4 Gefitinib Carcinoma (Cell Line: MCF7) [3]
Indazole derivative 5 + Digitoxin DCM306V Indazole derivative 5 Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [2]
Indazole derivative 5 + Digitoxin DC90Z56 Indazole derivative 5 Anaplastic large cell lymphoma (Cell Line: SR) [2]
Indazole derivative 5 + Digitoxin DCASYIT Indazole derivative 5 Carcinoma (Cell Line: MCF7) [3]
Indazole derivative 5 + Digitoxin DCG4HOI Indazole derivative 5 Invasive ductal carcinoma (Cell Line: T-47D) [3]
Indazole derivative 5 + Digitoxin DCLPJNS Indazole derivative 5 Amelanotic melanoma (Cell Line: MDA-MB-435) [4]
JNK-IN-8 + Digitoxin DC09BFW JNK-IN-8 Anaplastic large cell lymphoma (Cell Line: SR) [2]
JNK-IN-8 + Digitoxin DCLES7L JNK-IN-8 Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
Lenalidomide + Digitoxin DC180UQ Lenalidomide Cutaneous melanoma (Cell Line: SK-MEL-5) [4]
Letrozole + Digitoxin DCFPO5Z Letrozole High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [2]
LIAROZOLE + Digitoxin DCA0KGO LIAROZOLE Anaplastic large cell lymphoma (Cell Line: SR) [2]
Mechlorethamine + Digitoxin DCNKQ6P Mechlorethamine Colon carcinoma (Cell Line: KM12) [3]
Mechlorethamine + Digitoxin DCNNYGC Mechlorethamine Invasive ductal carcinoma (Cell Line: T-47D) [3]
Mechlorethamine + Digitoxin DCTZLPY Mechlorethamine Amelanotic melanoma (Cell Line: MDA-MB-435) [4]
Ruxolitinib + Digitoxin DCMF1XI Ruxolitinib Carcinoma (Cell Line: MCF7) [3]
Thioguanine + Digitoxin DCJXNV2 Thioguanine Anaplastic large cell lymphoma (Cell Line: SR) [2]
Thioguanine + Digitoxin DC1GAOS Thioguanine Glioblastoma (Cell Line: SNB-75) [2]
Thioguanine + Digitoxin DC7Q6R1 Thioguanine Glioma (Cell Line: SF-295) [2]
Thioguanine + Digitoxin DCT7LTX Thioguanine Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [4]
Topotecan + Digitoxin DCOUW8V Topotecan Carcinoma (Cell Line: MCF7) [3]
Topotecan + Digitoxin DCSDBKT Topotecan Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [4]
Topotecan + Digitoxin DC053EN Topotecan Amelanotic melanoma (Cell Line: MDA-MB-435) [4]
Topotecan + Digitoxin DCDY80T Topotecan Cutaneous melanoma (Cell Line: SK-MEL-28) [4]
Topotecan + Digitoxin DC12I92 Topotecan Glioma (Cell Line: SF-268) [4]
Topotecan + Digitoxin DC120SR Topotecan Lung adenocarcinoma (Cell Line: EKVX) [4]
Topotecan + Digitoxin DCS4XV9 Topotecan Melanoma (Cell Line: MALME-3M) [4]
Topotecan + Digitoxin DCGRATT Topotecan Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [4]
Topotecan + Digitoxin DC1770M Topotecan Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [4]
Topotecan + Digitoxin DCTUAY5 Topotecan Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
Topotecan + Digitoxin DCUSFKC Topotecan Papillary renal cell carcinoma (Cell Line: ACHN) [4]
Topotecan + Digitoxin DCTHN3V Topotecan Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [4]
Trifluridine + Digitoxin DC99OBA Trifluridine Anaplastic large cell lymphoma (Cell Line: SR) [2]
Trifluridine + Digitoxin DCLGIQG Trifluridine Astrocytoma (Cell Line: SNB-19) [2]
Trifluridine + Digitoxin DCVX6T8 Trifluridine Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [2]
Trifluridine + Digitoxin DCUB1XH Trifluridine Lung adenocarcinoma (Cell Line: EKVX) [4]
Vandetanib + Digitoxin DCMNLFS Vandetanib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [4]
Vandetanib + Digitoxin DCFDU8Z Vandetanib Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [4]
Vemurafenib + Digitoxin DCJCFJA Vemurafenib Invasive ductal carcinoma (Cell Line: HS 578T) [3]
Vemurafenib + Digitoxin DC6B93R Vemurafenib Clear cell renal cell carcinoma (Cell Line: TK-10) [4]
Vemurafenib + Digitoxin DC81K2X Vemurafenib Cutaneous melanoma (Cell Line: SK-MEL-5) [4]
Vemurafenib + Digitoxin DCNSU76 Vemurafenib Melanoma (Cell Line: UACC-257) [4]
Vemurafenib + Digitoxin DCLBAMM Vemurafenib Plasma cell myeloma (Cell Line: RPMI-8226) [4]
Vincristine + Digitoxin DCEDT1D Vincristine Invasive ductal carcinoma (Cell Line: T-47D) [3]
Vismodegib + Digitoxin DCO2RD0 Vismodegib Breast adenocarcinoma (Cell Line: MDA-MB-468) [3]
Vismodegib + Digitoxin DCGXIJ6 Vismodegib Cutaneous melanoma (Cell Line: SK-MEL-5) [4]
Vismodegib + Digitoxin DCB1RWU Vismodegib Large cell lung carcinoma (Cell Line: NCI-H460) [4]
Vismodegib + Digitoxin DCFHNRK Vismodegib Malignant melanoma (Cell Line: LOX IMVI) [4]
Vismodegib + Digitoxin DCUHPNB Vismodegib Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [4]
------------------------------------------------------------------------------------
⏷ Show the Full List of 267 DrugCom(s)

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6782).
2 Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension.Hepatology. 2016 Jun;63(6):1977-86. doi: 10.1002/hep.28499. Epub 2016 Mar 31.
3 Biologically active neutrophil chemokine pattern in tonsillitis.Clin Exp Immunol. 2004 Mar;135(3):511-8. doi: 10.1111/j.1365-2249.2003.02390.x.
4 Loss of function mutations in VARS encoding cytoplasmic valyl-tRNA synthetase cause microcephaly, seizures, and progressive cerebral atrophy.Hum Genet. 2018 Apr;137(4):293-303. doi: 10.1007/s00439-018-1882-3. Epub 2018 Apr 24.